The Advancing Nuclear Medicine consortium, led by the Nuclear Research and Consultancy Group, has been awarded a EUR6.8 million (USD7.7 million) subsidy to develop FIELD-LAB. This Dutch initiative is aimed at accelerating the development and introduction of new radiopharmaceuticals.
New Nuclear 18 January 2019
The High Flux Reactor at Petten in the Netherlands is now producing the medical radioisotope Xenon-133. The move follows the successful collaboration between nuclear medicine company Curium and the Nuclear Research and Consultancy Group to develop and install a production process for the isotope.
Regulation & Safety 15 May 2018
The Ichos consortium has been selected to design and construct the Pallas research reactor, which is to be built at Petten in the Netherlands to replace the existing High Flux Reactor. The consortium comprises Argentinean nuclear technology firm Invap, together with Croonwolter&dros and Mobilis, both part of TBI Holdings of the Netherlands.
New Nuclear 25 January 2018